Item Type | Name |
Academic Article
|
Serum thyroxine change and clinical recovery in psychiatric inpatients.
|
Academic Article
|
Serum testosterone differences between patients with schizophrenia and those with affective disorder.
|
Academic Article
|
Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder.
|
Academic Article
|
Urinary free-cortisol levels in posttraumatic stress disorder patients.
|
Academic Article
|
Significant interaction between clozapine and cocaine in cocaine addicts.
|
Academic Article
|
Effects of smoking abstinence on visuospatial working memory function in schizophrenia.
|
Academic Article
|
Substance abuse and schizophrenia: editors' introduction.
|
Academic Article
|
A placebo controlled trial of bupropion for smoking cessation in schizophrenia.
|
Academic Article
|
Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia.
|
Academic Article
|
Disrupted antioxidant enzyme activity and elevated lipid peroxidation products in schizophrenic patients with tardive dyskinesia.
|
Academic Article
|
Association between interleukin-6 receptor polymorphism and patients with schizophrenia.
|
Academic Article
|
Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics.
|
Academic Article
|
Association between monoamine oxidase (MAO)-A gene variants and schizophrenia in a Chinese population.
|
Academic Article
|
Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
|
Academic Article
|
Smoking initiation and schizophrenia: a replication study in a Chinese Han population.
|
Academic Article
|
Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical and atypical antipsychotics.
|
Academic Article
|
Smoking and tardive dyskinesia in male patients with chronic schizophrenia.
|
Academic Article
|
Association of catechol-O-methyltransferase gene polymorphisms with schizophrenia and negative symptoms in a Chinese population.
|
Academic Article
|
The dopamine b-hydroxylase 19 bp insertion/deletion polymorphism was associated with first-episode but not medicated chronic schizophrenia.
|
Academic Article
|
No association between the type 2 diabetes mellitus susceptibility gene, SLC30A8 and schizophrenia in a Chinese population.
|
Academic Article
|
Gender differences in cognitive function of patients with chronic schizophrenia.
|
Academic Article
|
Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients.
|
Academic Article
|
Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia.
|
Academic Article
|
Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population.
|
Academic Article
|
Brain-derived neurotrophic factor polymorphisms and smoking in schizophrenia.
|
Academic Article
|
Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics.
|
Academic Article
|
Nicotine dependence, symptoms and oxidative stress in male patients with schizophrenia.
|
Academic Article
|
Multidimensional hormonal discrimination of paranoid schizophrenic from bipolar manic patients.
|
Academic Article
|
Lack of association between the BDNF C270T polymorphism and schizophrenia in a Chinese Han population.
|
Academic Article
|
BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia.
|
Academic Article
|
Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics.
|
Academic Article
|
Elevated serum levels of tumor necrosis factor-alpha in clozapine-associated obesity in chronic schizophrenia.
|
Academic Article
|
Altered interleukin-3 serum levels in drug-na?ve and neuroleptic-treated schizophrenic patients.
|
Academic Article
|
Gender differences in the prevalence, risk and clinical correlates of tardive dyskinesia in Chinese schizophrenia.
|
Academic Article
|
Aripiprazole treatment of risperidone-induced hyperprolactinemia.
|
Academic Article
|
The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients.
|
Academic Article
|
Decreased levels of serum brain-derived neurotrophic factor in drug-na?ve first-episode schizophrenia: relationship to clinical phenotypes.
|
Academic Article
|
Increased S100B serum levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
|
Academic Article
|
Sex difference in the prevalence of smoking in Chinese schizophrenia.
|
Academic Article
|
The study of BDNF Val66Met polymorphism in Chinese schizophrenic patients.
|
Academic Article
|
Association of the manganese superoxide dismutase gene Ala-9Val polymorphism with clinical phenotypes and tardive dyskinesia in schizophrenic patients.
|
Academic Article
|
Gender differences in the prevalence of diabetes mellitus in chronic hospitalized patients with schizophrenia on long-term antipsychotics.
|
Academic Article
|
Reduced status of plasma total antioxidant capacity in schizophrenia with tardive dyskinesia.
|
Academic Article
|
Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia.
|
Academic Article
|
Association between TNF-a promoter -308A/G polymorphism and tardive dyskinesian Chinese Han patients with schizophrenia.
|
Academic Article
|
Cigarette smoking in male patients with chronic schizophrenia in a Chinese population: prevalence and relationship to clinical phenotypes.
|
Academic Article
|
Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.
|
Academic Article
|
Association of functional dopamine-beta-hydroxylase (DBH) 19 bp insertion/deletion polymorphism with smoking severity in male schizophrenic smokers.
|
Academic Article
|
Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls.
|
Academic Article
|
Interleukin 18 and cognitive impairment in first episode and drug na?ve schizophrenia versus healthy controls.
|
Academic Article
|
Clinical symptoms and cognitive impairment associated with male schizophrenia relate to plasma manganese superoxide dismutase activity: a case-control study.
|
Academic Article
|
The type 2 diabetes mellitus susceptibility gene IGF2BP2 is associated with schizophrenia in a Han Chinese population.
|
Academic Article
|
Lower serum interleukin-2 levels in schizophrenic patients with tardive dyskinesia.
|
Academic Article
|
Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology.
|
Academic Article
|
Association of the dopamine ?-hydroxylase 19 bp insertion/deletion polymorphism with positive symptoms but not tardive dyskinesia in schizophrenia.
|
Academic Article
|
Differential diagnosis of psychiatric comorbidity in substance abusers.
|
Academic Article
|
Elevation of urinary norepinephrine/cortisol ratio in posttraumatic stress disorder.
|
Academic Article
|
Nicotine dependence and schizophrenia.
|
Academic Article
|
Treatment of dual diagnosis patients: a relapse prevention group approach.
|
Academic Article
|
The CCR5 32-bp deletion allele is rare in a Chinese population.
|
Academic Article
|
Association between interleukin-3 receptor alpha polymorphism and schizophrenia in the Chinese population.
|
Academic Article
|
Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics.
|
Academic Article
|
The Val66Met polymorphism of the brain-derived neurotrophic factor gene is not associated with risk for schizophrenia and tardive dyskinesia in Han Chinese population.
|
Academic Article
|
Reduced plasma total antioxidant status in first-episode drug-naive patients with schizophrenia.
|
Academic Article
|
The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine.
|
Academic Article
|
Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia.
|
Academic Article
|
Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.
|
Academic Article
|
Plasma total antioxidant status and cognitive impairments in schizophrenia.
|
Academic Article
|
Cigarette smoking and cognitive function in Chinese male schizophrenia: a case-control study.
|
Academic Article
|
Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba.
|
Academic Article
|
Association between DBH 19 bp insertion/deletion polymorphism and cognition in first-episode schizophrenic patients.
|
Academic Article
|
Serum thyroxine levels in schizophrenic and affective disorder diagnostic subgroups.
|
Concept
|
Schizophrenia
|
Concept
|
Schizophrenia, Paranoid
|
Academic Article
|
Free radicals, antioxidant defense systems, and schizophrenia.
|
Academic Article
|
Prevalence, demographic and clinical correlates of suicide attempts in Chinese medicated chronic inpatients with schizophrenia.
|
Academic Article
|
Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia.
|
Academic Article
|
Association of BDNF gene polymorphisms with schizophrenia and clinical symptoms in a Chinese population.
|
Academic Article
|
Diabetes and cognitive deficits in chronic schizophrenia: a case-control study.
|
Academic Article
|
The interaction of polymorphisms of IL10 and DBH was associated with general symptoms of PANSS with TD in Chinese Han schizophrenic patients.
|
Academic Article
|
Socio-demographic and clinical characteristics of heavy and non-heavy smokers among schizophrenia inpatients in a Chinese Han population.
|
Academic Article
|
Cognitive function, plasma MnSOD activity, and MnSOD Ala-9Val polymorphism in patients with schizophrenia and normal controls.
|
Academic Article
|
Interaction of BDNF with cytokines in chronic schizophrenia.
|
Academic Article
|
Extensive white matter abnormalities and clinical symptoms in drug-naive patients with first-episode schizophrenia: a voxel-based diffusion tensor imaging study.
|
Academic Article
|
Smoking reduction and quality of life in chronic patients with schizophrenia in a Chinese population--A pilot study.
|
Academic Article
|
Serum IL-18 level, clinical symptoms and IL-18-607A/C polymorphism among chronic patients with schizophrenia in a Chinese Han population.
|
Academic Article
|
Smoking and Serum Lipid Profiles in Schizophrenia.
|
Academic Article
|
Contribution of IL-10 and its -592 A/C polymorphism to cognitive functions in first-episode drug-naive schizophrenia.
|
Academic Article
|
Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: Association with pro-inflammatory cytokine levels.
|
Grant
|
Tropisetron with Risperidone for Schizophrenia
|
Academic Article
|
Hospital Stay in Synthetic Cannabinoid Users With Bipolar Disorder, Schizophrenia, or Other Psychotic Disorders Compared With Cannabis Users.
|
Academic Article
|
The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia.
|
Academic Article
|
One-day tropisetron treatment improves cognitive deficits and P50 inhibition deficits in schizophrenia.
|
Academic Article
|
Cognitive Deficits and Clinical Symptoms with Hippocampal Subfields in First-Episode and Never-Treated Patients with Schizophrenia.
|
Academic Article
|
Genome-Wide Association Studies of Schizophrenia and Bipolar Disorder in a Diverse Cohort of US Veterans.
|
Academic Article
|
Low-Dose Ziprasidone in Combination with Sertraline for First-Episode Drug-Na?ve Patients with Schizophrenia: a Randomized Controlled Trial.
|
Academic Article
|
P50 inhibition defects, psychopathology and gray matter volume in patients with first-episode drug-naive schizophrenia.
|
Academic Article
|
Association between MnSOD Activity and Cognitive Impairment in Unmedicated First-Episode Schizophrenia: Regulated by MnSOD Ala-9Val Gene Polymorphism.
|
Academic Article
|
Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia, Bipolar Disorder, and Depression Among Adults in the US Veterans Affairs Health Care System.
|
Academic Article
|
Correlates of suicidal behaviors and genetic risk among United States veterans with schizophrenia or bipolar I disorder.
|
Academic Article
|
Dynamic functional thalamocortical dysconnectivity in schizophrenia correlates to antipsychotics response.
|
Academic Article
|
A double-blind, randomized controlled study of the effects of celecoxib on clinical symptoms and cognitive impairment in patients with drug-na?ve first episode schizophrenia: pharmacogenetic impact of cyclooxygenase-2 functional polymorphisms.
|
Academic Article
|
Correlates of Risk for Disinhibited Behaviors in the Million Veteran Program Cohort.
|
Academic Article
|
Correlates of suicidal behaviors and genetic risk among United States veterans with schizophrenia or bipolar I disorder.
|